A Prospective Comparative Study of the Toxicity Profile of 5-Flurouracil, Adriamycin, Cyclophosphamide Regime VS Adriamycin, Paclitaxel Regime in Patients with Locally Advanced Breast Carcinoma

A Prospective Comparative Study of the Toxicity Profile of 5-Flurouracil, Adriamycin, Cyclophosphamide Regime VS Adriamycin, Paclitaxel Regime in Patients with Locally Advanced Breast Carcinoma

Introduction: A 5-flurouracil, Adriamycin, Cyclophosphamide (FAC) and Adriamycin, Paclitaxel (AT) are two popular chemotherapeutic regimens for treatment of breast carcinoma. The most time tested and popular regimen is FAC. It is extensively studied for efficacy and toxicity. But data regarding...

Full description

Bibliographic Details
Main Authors: Jihana Shajahan, Pradeep Sadasivan Pillai, Krishnan Nair Lalithamma Jayakumar
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-12-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
clinical response
chemotherapy
tumour size
who toxicity criteria
Online Access:https://jcdr.net/articles/PDF/6864/15939_CE[Ra1]_F(GH)_PF1(Ek_Om)_PFA(AK)_PF2(PAG).pdf

Internet

https://jcdr.net/articles/PDF/6864/15939_CE[Ra1]_F(GH)_PF1(Ek_Om)_PFA(AK)_PF2(PAG).pdf

Similar Items